[HTML][HTML] Recent advances in heat shock proteins in cancer diagnosis, prognosis, metabolism and treatment
S Yang, H Xiao, L Cao - Biomedicine & Pharmacotherapy, 2021 - Elsevier
Heat shock proteins (HSPs) are a group of proteins, also known as molecular chaperones,
which participate in protein folding and maturation in response to stresses or high …
which participate in protein folding and maturation in response to stresses or high …
[HTML][HTML] Targeting HSF1 for cancer treatment: Mechanisms and inhibitor development
Y Chin, KE Gumilar, XG Li, BA Tjokroprawiro, CH Lu… - Theranostics, 2023 - ncbi.nlm.nih.gov
Abstract Heat Shock Factor 1 (HSF1) is a master regulator of heat shock responsive
signaling. In addition to playing critical roles in cellular heat shock response, emerging …
signaling. In addition to playing critical roles in cellular heat shock response, emerging …
Inhibiting heat shock factor 1 in cancer: a unique therapeutic opportunity
B Dong, AM Jaeger, DJ Thiele - Trends in pharmacological sciences, 2019 - cell.com
The ability of cancer cells to cope with stressful conditions is critical for their survival,
proliferation, and metastasis. The heat shock transcription factor 1 (HSF1) protects cells from …
proliferation, and metastasis. The heat shock transcription factor 1 (HSF1) protects cells from …
Emerging roles of HSF1 in cancer: Cellular and molecular episodes
G Wang, P Cao, Y Fan, K Tan - … et Biophysica Acta (BBA)-Reviews on …, 2020 - Elsevier
Abstract Heat shock factor 1 (HSF1) systematically guards proteome stability and
proteostasis by regulating the expression of heat shock protein (HSP), thus rendering cancer …
proteostasis by regulating the expression of heat shock protein (HSP), thus rendering cancer …
Targeting the heat shock response induced by modulated electro-hyperthermia (mEHT) in cancer
Abstract The Heat Shock Response (HSR) is a cellular stress reaction crucial for cell survival
against stressors, including heat, in both healthy and cancer cells. Modulated electro …
against stressors, including heat, in both healthy and cancer cells. Modulated electro …
The tumour-promoting role of protein homeostasis: Implications for cancer immunotherapy
Protein homeostasis, an important aspect of cellular fitness that encompasses the balance of
production, folding and degradation of proteins, has been linked to several diseases of the …
production, folding and degradation of proteins, has been linked to several diseases of the …
Targeted inhibition of mTOR by BML-275 induces mitochondrial-mediated apoptosis and autophagy in prostate cancer
W Li, D Li, Q Ma, Y Chen, Z Hu, Y Bai, L Xie - European Journal of …, 2023 - Elsevier
Prostate cancer (PCa) is the most frequently diagnosed cancer among men and the second
leading cause of death in Western countries. Clinically, screening drugs and develop …
leading cause of death in Western countries. Clinically, screening drugs and develop …
Drug repurposing based on differentially expressed genes suggests drug combinations with possible synergistic effects in treatment of lung adenocarcinoma
L Yesharim, S Teimourian - Cancer Biology & Therapy, 2023 - Taylor & Francis
Lung adenocarcinoma is one of the leading causes of cancer-related mortality globally.
Various treatment approaches and drugs had little influence on overall survival; thus, new …
Various treatment approaches and drugs had little influence on overall survival; thus, new …
[HTML][HTML] Heat Shock Factor 1 Inhibition: A Novel Anti-Cancer Strategy with Promise for Precision Oncology
Simple Summary Heat shock factor 1 (HSF1) is a transcription factor crucial for cellular
stress responses. HSF1 activates heat shock proteins (HSPs) in response to proteotoxic …
stress responses. HSF1 activates heat shock proteins (HSPs) in response to proteotoxic …
AMPK inhibition sensitizes acute leukemia cells to BH3 mimetic-induced cell death
J Jia, W Ji, AN Saliba, CM Csizmar, K Ye, L Hu… - Cell Death & …, 2024 - nature.com
BH3 mimetics, including the BCL2/BCLXL/BCLw inhibitor navitoclax and MCL1 inhibitors
S64315 and tapotoclax, have undergone clinical testing for a variety of neoplasms. Because …
S64315 and tapotoclax, have undergone clinical testing for a variety of neoplasms. Because …